Search Result "CCI779"
Combined Treatment with CCI779 and SB203580 Induces Cellular Senescence in Renal Cell Carcinoma Cell Line via p53 Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 11 Year: 2017 Page: 1545-1554
Author(s): Ashutosh Chauhan,Rani Ojha,Deepak K. Semwal,Satyendra P. Mishra,Ruchi B. Semwal
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang
Perspectives on mTOR Inhibitors for Castration-Refractory Prostate Cancer
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 8 Year: 2012 Page: 940-949
Author(s): Salvatore L. Burgio,Francesco Fabbri,Ian J. Seymour,Wainer Zoli,Dino Amadori,Ugo De Giorgi
Recent Patents on Melanoma with Focus on Genetic Strategies
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 3 Issue: 2 Year: 2008 Page: 136-144
Author(s): Talia Gramiccia, Rosita Saraceno, Alessandro D. Stefani, Sergio Chimenti, Alessandro Di Stefani
Neurological Complications of Antiangiogenic Therapy
Ebook: Anti-Angiogenesis Drug Discovery and Development
Volume: 1 Year: 2011
Author(s): Jose Tarcisio Feitosa Vieira da Silva,Italo Gustavo Lima Monteiro,Carlos Tairo Diogenes Holanda,Francisco de Assis Aquino Gondim
Doi: 10.2174/978160805162511101010148
The Akt-mTOR Pathway in Downâs Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 34-40
Author(s): Jose Antonio Troca-Marin,Juan Jose Casanas,Itziar Benito,Maria Luz Montesinos
Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
Journal: Current Molecular Medicine
Volume: 15 Issue: 1 Year: 2015 Page: 82-93
Author(s): V. Dimitrova,A. Arcaro
Inhibition of IL-2 Production by Novel Small Molecules using Building Blocks from Reduced Chalcones and a Substituted Proline
Journal: Current Drug Therapy
Volume: 13 Issue: 2 Year: 2018 Page: 130-139
Author(s): Esteban F. Duran-Lara,Wender A. da Silva,Luis Guzman,Ricardo Castro,Carlos Kleber Z. Andrade,Leonardo S. Santos
Disrupting the mTOR Signaling Network as a Potential Strategy for the Enhancement of Cancer Radiotherapy
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 8 Year: 2012 Page: 899-924
Author(s): Francis J. Dumont,Pierre Bischoff
Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 3 Year: 2013 Page: 464-475
Author(s): Jinjia Chang,Weimin Fan